{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:06:44Z","timestamp":1793016404515,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.prp.2021.153678","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T11:04:56Z","timestamp":1635505496000},"page":"153678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Genomic alteration in rare subtype of sarcomatoid salivary duct carcinoma"],"prefix":"10.1016","volume":"228","author":[{"given":"Ji-Seon","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Ja","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deokhoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Se","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7429-4254","authenticated-orcid":false,"given":"Joon Seon","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2021.153678_bib1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/PAS.0000000000000413","article-title":"Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression","volume":"39","author":"Williams","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153678_bib2","series-title":"WHO Classification of Head and Neck Tumours","author":"El-Naggar","year":"2017"},{"key":"10.1016\/j.prp.2021.153678_bib3","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1002\/cncr.21116","article-title":"Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases","volume":"103","author":"Jaehne","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2021.153678_bib4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/his.12152","article-title":"An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions","volume":"63","author":"Bahrami","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2021.153678_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1158\/2159-8290.CD-11-0184","article-title":"High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing","volume":"2","author":"Wagle","year":"2012","journal-title":"Cancer Disco"},{"key":"10.1016\/j.prp.2021.153678_bib6","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.prp.2021.153678_bib7","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"10.1016\/j.prp.2021.153678_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.prp.2021.153678_bib9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.prp.2021.153678_bib10","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/bioinformatics\/btq330","article-title":"Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor","volume":"26","author":"McLaren","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.prp.2021.153678_bib11","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1093\/bioinformatics\/btv408","article-title":"SomaticSignatures: inferring mutational signatures from single-nucleotide variants","volume":"31","author":"Gehring","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.prp.2021.153678_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.prp.2021.153678_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Disco"},{"key":"10.1016\/j.prp.2021.153678_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.prp.2021.153678_bib15","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1158\/1078-0432.CCR-14-1746","article-title":"Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications","volume":"20","author":"Mitani","year":"2014","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.prp.2021.153678_bib16","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.5858\/arpa.2018-0902-SA","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology\/college of American pathologists clinical practice guideline focused update","volume":"142","author":"Wolff","year":"2018","journal-title":"Arch. Pathol. Lab Med"},{"key":"10.1016\/j.prp.2021.153678_bib17","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/hed.23350","article-title":"Survival rates and prognostic factors for infiltrating salivary duct carcinoma: analysis of 228 cases from the surveillance, epidemiology, and end results database","volume":"36","author":"Jayaprakash","year":"2014","journal-title":"Head. Neck"},{"key":"10.1016\/j.prp.2021.153678_bib18","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/00000478-200407000-00017","article-title":"Osteoclast-type giant cell neoplasm of salivary gland. A microdissection-based comparative genotyping assay and literature review: extraskeletal \u201cgiant cell tumor of bone\u201d or osteoclast-type giant cell \u201ccarcinoma\u201d?","volume":"28","author":"Tse","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153678_bib19","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1177\/014556130708601016","article-title":"Osteoclast-like giant-cell tumor of the parotid with salivary duct carcinoma: case report and cytologic, histologic, and immunohistochemical findings","volume":"86","author":"Kadivar","year":"2007","journal-title":"Ear Nose Throat J."},{"key":"10.1016\/j.prp.2021.153678_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4132\/KoreanJPathol.2012.46.3.297","article-title":"Osteoclast-like giant cell tumor of parotid gland with a carcinomatous component: a case report","volume":"46","author":"Yang","year":"2012","journal-title":"Korean J. Pathol."},{"key":"10.1016\/j.prp.2021.153678_bib21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4103\/0973-1482.113406","article-title":"Low to intermediate grade salivary duct carcinoma associated with osteoclast like-giant cell tumor of parotid gland: a rare case with distinct pathological features","volume":"9","author":"Pasricha","year":"2013","journal-title":"J. Cancer Res Ther."},{"issue":"Suppl 1","key":"10.1016\/j.prp.2021.153678_bib22","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1007\/s12105-013-0456-x","article-title":"Salivary duct carcinoma: new developments--morphological variants including pure in situ high grade lesions; proposed molecular classification","volume":"7","author":"Simpson","year":"2013","journal-title":"Head. Neck Pathol."},{"key":"10.1016\/j.prp.2021.153678_bib23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1600-0714.1997.tb00244.x","article-title":"The spectrum of giant cells in tumours of the salivary glands: an analysis of 11 cases","volume":"26","author":"Donath","year":"1997","journal-title":"J. Oral. Pathol. Med"},{"key":"10.1016\/j.prp.2021.153678_bib24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/cncy.22288","article-title":"Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment","volume":"128","author":"Nakaguro","year":"2020","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.prp.2021.153678_bib25","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1002\/cam4.2602","article-title":"Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling","volume":"8","author":"Gargano","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.prp.2021.153678_bib26","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1158\/1078-0432.CCR-15-2568","article-title":"Profiling of 149 salivary duct carcinomas, carcinoma ex pleomorphic adenomas, and adenocarcinomas, not otherwise specified reveals actionable genomic alterations","volume":"22","author":"Wang","year":"2016","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.prp.2021.153678_bib27","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/cncr.30179","article-title":"Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations","volume":"122","author":"Chiosea","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2021.153678_bib28","doi-asserted-by":"crossref","first-page":"75261","DOI":"10.18632\/oncotarget.12127","article-title":"MDM2 and CDK4 amplifications are rare events in salivary duct carcinomas","volume":"7","author":"Gr\u00fcnewald","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2021.153678_bib29","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.18632\/oncotarget.22927","article-title":"Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas","volume":"9","author":"Shimura","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2021.153678_bib30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1158\/0008-5472.CAN-12-1726","article-title":"PIK3CA mutation H1047R is associated with response to PI3K\/AKT\/mTOR signaling pathway inhibitors in early-phase clinical trials","volume":"73","author":"Janku","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2021.153678_bib31","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1158\/1078-0432.CCR-12-1842","article-title":"Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment","volume":"19","author":"Nardi","year":"2013","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.prp.2021.153678_bib32","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMoa1502309","article-title":"Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations","volume":"373","author":"Hyman","year":"2015","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.prp.2021.153678_bib33","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.6004\/jnccn.2018.7056","article-title":"First-line treatment of widely metastatic BRAF-mutated salivary duct carcinoma with combined BRAF and MEK inhibition","volume":"16","author":"Lin","year":"2018","journal-title":"J. Natl. Compr. Canc Netw."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033821003393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033821003393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:48:49Z","timestamp":1759733329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033821003393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":33,"alternative-id":["S0344033821003393"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2021.153678","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic alteration in rare subtype of sarcomatoid salivary duct carcinoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2021.153678","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153678"}}